LBRXLB PHARMACEUTICALS INCvs its industry peers
A metric-by-metric comparison of LB PHARMACEUTICALS INC against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBRXThis | $1.3B#8 | 1.7x#1 | 3.8x#9 | — | — | 60.1%#2 | — | -7.6%#3 | — | — | 140.8%#4 | — |
| ETON | $1.4B#1 | — | 30.6x#10 | 17.8x#4 | 104.9%#2 | -20.4%#5 | -1.1%#2 | -9.9%#4 | -1.8%#2 | 4#2 | 176.2%#2 | — |
| MLYS | $1.4B#2 | — | 2.6x#6 | — | — | 13.0%#3 | — | -28.1%#7 | -41.3%#5 | — | -60.5%#9 | — |
| KARD | $1.3B#3 | — | 2.2x#3 | — | — | — | — | 0.0%#2 | — | — | — | — |
| OMER | $1.3B#4 | 10.5x#3 | — | 17.9x#5 | -34.0%#5 | 97.9%#1 | -166.4%#5 | — | -151.8%#7 | — | 149.0%#3 | — |
| DMRA | $1.3B#5 | 2.7x#2 | 2.5x#4 | — | — | -878.8%#11 | — | -40.7%#9 | — | — | 183.2%#1 | — |
| NKTR | $1.3B#6 | — | 1.4x#2 | 23.3x#6 | -43.9%#6 | -37.8%#6 | -253.7%#6 | -18.2%#5 | -14.0%#4 | — | — | — |
| OPK | $1.3B#7 | — | 1.1x#1 | 2.1x#2 | -14.9%#4 | -324.0%#10 | -19.3%#3 | -19058.1%#10 | -13.3%#3 | 4#2 | 25.5%#6 | — |
| TYRA | $1.2B#9 | — | 3.5x#8 | — | — | -38.7%#8 | — | -33.9%#8 | — | — | 31.6%#5 | — |
| RAPP | $1.2B#10 | — | 2.8x#7 | — | — | -42.4%#9 | — | -26.4%#6 | — | — | -14.4%#8 | — |
| SNDX | $1.2B#11 | — | — | 6.8x#3 | 627.8%#1 | 10.5%#4 | -158.4%#4 | — | -143.0%#6 | — | -4.0%#7 | — |
| AMPH | $1.1B#12 | 15.9x#4 | 2.6x#5 | 1.6x#1 | -1.7%#3 | -38.5%#7 | 19.5%#1 | 22.0%#1 | 13.2%#1 | 5#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice